Contact information
Research groups
Ali Hosin
BSc (Hons) MBBS AICSM MRCP
DPhil student
Dr Ali Hosin is a Specialty Registrar in Clinical Pharmacology & Therapeutics and Internal Medicine. He is currently undertaking a DPhil at NDORMS, focusing on the evaluation of novel digital technologies in cardiovascular disease, using routinely collected healthcare data to assess their impact on safety, healthcare utilisation and patient outcomes. His research aims to bridge the gap between digital innovation and real-world cardiovascular care, with a particular focus on improving outcomes for patients with heart failure and related conditions.
After graduating from Imperial College School of Medicine, with an intercalated BSc in Medical Sciences with Pharmacology, Ali completed Academic Foundation Training at Guy’s and St Thomas’ Hospitals. This was followed by an NIHR Academic Clinical Fellowship in Clinical Pharmacology & Therapeutics at University College London Hospitals NHS Foundation Trust. During this time he gained experience in a range of research methodologies across basic science research and clinical trials.
Ali's interest in digital healthcare evaluation emerged during the Covid-19 pandemic when remote and technology-enabled healthcare interventions rapidly expanded outwith the traditional framework of clinical trials. He was awarded a Topol Digital Healthcare Fellowship, during which he led on the implementation and evaluation of app-enabled remote blood pressure (BP) monitoring of outpatients with hypertension. This led to him being awarded a place on the flagship Royal College of Physicians Chief Registrar programme where he worked on a pilot study of remote BP monitoring in high risk patients with acute stroke, at the National Hospital for Neurology & Neurosurgery, Queen Square. This work contributed to the growing evidence base for technology-driven approaches to cardiovascular disease management.
Ali is actively involved in medical education and delivers undergraduate and postgraduate teaching on prescribing, therapeutics and medication safety at UCL and Oxford Medical Schools.